Working… Menu

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 (PROPEL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04632381
Recruitment Status : Not yet recruiting
First Posted : November 17, 2020
Last Update Posted : May 6, 2021
Medpace, Inc.
Information provided by (Responsible Party):
Effector Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : October 29, 2021
Estimated Study Completion Date : December 31, 2021